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We used a porcine microarray containing 2,880 cDNAs to investigate the response of macrophages to
infection by a virulent African swine fever virus (ASFV) isolate, Malawi LIL20/1. One hundred twenty-five
targets were found to be significantly altered at either or both 4 h and 16 h postinfection compared with targets
after mock infection. These targets were assigned into three groups according to their temporal expression
profiles. Eighty-six targets showed increased expression levels at 4 h postinfection but returned to expression
levels similar to those in mock-infected cells at 16 h postinfection. These encoded several proinflammatory
cytokines and chemokines, surface proteins, and proteins involved in cell signaling and trafficking pathways.
Thirty-four targets showed increased expression levels at 16 h postinfection compared to levels at 4 h
postinfection and in mock-infected cells. One host gene showed increased expression levels at both 4 and 16 h
postinfection compared to levels in mock-infected cells. The microarray results were validated for 12 selected
genes by quantitative real-time PCR. Levels of protein expression and secretion were measured for two
proinflammatory cytokines, interleukin 1 and tumor necrosis factor alpha, during a time course of infection
with either the virulent Malawi LIL20/1 isolate or the OUR T88/3 nonpathogenic isolate. The results revealed
differences between these two ASFV isolates in the amounts of these cytokines secreted from infected cells.
African swine fever virus (ASFV) causes inapparent persis-
tent infections in its natural hosts, warthogs (Phacochoerus
aethiopicus), bushpigs (Potamochoerus porcus), and soft ticks
(Ornithodoros moubata), which inhabit warthog burrows. In
contrast, the virus causes an acute hemorrhagic fever with high
mortality rates in pigs, although some low-virulence isolates
have been reported (6, 33, 50, 52, 53).
The virus replicates in cells of the mononuclear phago-
cytic system and reticulo-endothelial cells of lymphoid tis-
sues and organs. Widespread apoptotic cell death occurs in
both T and B lymphocytes of lymphoid tissues (9, 21) and in
arteriolar and capillary endothelial cells (10, 15–17, 22).
Disseminated intravascular coagulation develops during the
late phase of acute infections, and this may lead to the
characteristic hemorrhagic syndrome (20, 22, 41).
ASFV is a large, icosahedral, double-stranded DNA virus
which replicates in the cytoplasm of infected cells and has been
classified as the only member of a new virus family (13), the
Asfarviridae. The genome encodes between 160 and 175 pro-
teins, including a number that interfere with host defense sys-
tems. These include proteins such as the A238L protein, which
inhibits both the activation of the host NF-B transcription
factor and calcineurin phosphatase activity. The latter inacti-
vation results in the inhibition of calcineurin-dependent path-
ways, such as activation of the nuclear factor of activated T cell
transcription factors (23, 24, 37, 38, 44, 47). Members of ASFV
multigene families 360 and 530 have been implicated in inhib-
iting the transcription of the beta interferon (IFN-) gene and
interferon-activated pathways (2).
To help understand how ASFV infection manipulates the
function of macrophages, we have used a porcine cDNA mi-
croarray containing 2,880 genes to investigate changes in mac-
rophage gene transcription that occur during in vitro infection
with a virulent isolate of ASFV (Malawi LIL20/1). We vali-
dated our microarray data by quantitative real-time PCR of 12
selected differentially expressed genes.
MATERIALS AND METHODS
Cells and viruses. Alveolar macrophages were collected by lung lavage from
Large White/Landrace crossbred piglets and cultured in RPMI 1640 medium
supplemented with 10% fetal cattle serum, penicillin-streptomycin, and fungi-
zone. Bone marrow cells were obtained from piglet femurs. Adherent cell pop-
ulations were selected after overnight culture.
The high-virulence isolate Malawi LILl20/1 (26) and the low-virulence isolate
OUR T88/3 (6) were grown in primary pig bone marrow cells, and virus was
purified by OptiPrep (Axis-Shield PoC AS, Oslo, Norway) gradient centrifuga-
tion and ultrafiltration. Hemadsorption or an indirect immunofluorescence assay
which detects an early viral protein, p30 (1), was used to titrate virus by limiting
dilution. Indirect immunofluorescence was also used to monitor the infection
rate of macrophage cultures.
Infection and stimulation of cells. Macrophages were infected at a multiplicity
of infection of 5 to 10. Uninfected cells were stimulated by culturing them in the
complete medium supplemented with 1 g/ml of lipopolysaccharide (LPS;
Sigma). In parallel, cells were mock treated without the addition of virus or LPS.
Microarray. Details of the porcine cDNA immunomicroarray used are avail-
able at www.arkgenomics.org, and the data are available from ArrayExpress
under accession number A-MEXP-494. This array contains 2,880 porcine cDNAs
selected by targeted gene cloning and from subtracted libraries.
RNA isolation. Total RNA was isolated from cells using TriReagent (Sigma)
followed by purification on QIAGEN RNeasy columns. RNA quality was as-
sessed on an Agilent 2100 bioanalyzer with an RNA 600 LabChip kit.
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RNA labeling and hybridizations to microarrays. Labeled cDNA probes were
produced using the Stratagene Fairplay microarray labeling kit. Twenty micro-
grams of total RNA was labeled for each sample to be used in a hybridization.
Labeled cDNAs were then purified using a DyeEx spin column. Labeling effi-
ciency was checked by running a sample on an agarose gel and visualizing the
fluorescence using an LSIV scanner (Genomic Solutions, Cambridge, United
Kingdom). Labeled cDNAs were added to the hybridization solution (Ultrahyb;
Ambion, Huntingdon, United Kingdom) and hybridized to microarrays for 18 h
at 42°C, and then slides were washed at 42°C. Slides were scanned using a
ScanArray 5000XL instrument (PerkinElmer, Cambridge, United Kingdom).
Data analysis. Raw data (spot intensity and background measurements) were
extracted by using Quantarray and normalized in Genespring per spot and per
chip (Lowess); then, in-slide averaging was done of the duplicate targets on each
array. A one-way analysis of variance algorithm was used to identify differentially
regulated targets with a t test P of 0.05.
Real-time PCR. RNA was converted into cDNA by using Onimus reverse
transcriptase (QIAGEN). A QuantiTect SYBR green PCR kit (QIAGEN) was
used for the PCRs on a GeneAmp 5700 system (PerkinElmer), and cycle thresh-
old values were extracted by using GeneAmp 5700 SDS software. The relative
expression levels of the selected genes were calculated (42), using beta-actin as
the internal control.
Enzyme-linked immunosorbent assays (ELISA). Quantikine immunoassay
kits (R & D Systems) were used to measure levels of porcine interleukin 1
(IL-1).
SDS-polyacrylamide gel electrophoresis and Western blotting. Alveolar mac-
rophages were either mock infected, treated with LPS (1 g/ml), or infected with
the ASFV Malawi LIL20/1 or OUR T88/3 isolate. At designated time points,
culture supernatants were harvested and cells were washed with cold phosphate-
buffered saline and lysed in 200 l of RIPA buffer (50 mM Tris-HCl [pH 7.4], 150
mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 5 g/ml aproti-
nin, 5 g/ml leupeptin, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium
dodecyl sulfate [SDS]). Clarified supernatants were resolved on 12% SDS-poly-
acrylamide gels before transfer to nitrocellulose membranes. To detect IL-1, a
mouse monoclonal antibody (clone 77724; R & D Systems) was used at a
concentration of 1 g/ml, and as a loading control, an antibody against -actin
(code no. JM-3598-100; MBL International) was used at a concentration of 1
g/ml. A goat anti-mouse immunoglobulin G (IgG) horseradish peroxidase con-
jugate (Promega) was used as the secondary antibody at a dilution of 1:2,500, and
bound antibodies were detected by enhanced chemiluminescence. To detect
tumor necrosis factor alpha (TNF-), a goat IgG anti-porcine TNF- (AF690;
R&D) was used, and bound antibodies were detected using protein G conjugated
to horseradish peroxidase (catalog no. ab7460-1; Abcam) followed by ECL.
RESULTS
Experimental design. RNA was harvested from porcine
macrophages infected with the virulent ASFV isolate Malawi
LIL20/1 at one time point (4 h postinfection) early in the virus
replication cycle when virus had entered cells and early protein
synthesis had begun and at one time point late in infection (16
h postinfection) when the switch to late virus gene expression
has occurred and the production of progeny virions was in
progress but cell death was not yet evident (13). Pilot experi-
ments showed little change in macrophage gene expression at
4 and 16 h following mock- infection, and we therefore used
pooled samples from mock-infected macrophages at 4 and 16 h
as the control in our experiments. A triangular-loop design was
used comparing RNA from mock-infected macrophages with
that from macrophages infected for either 4 h or 16 h. In
addition, a direct comparison of RNA from macrophages in-
fected for 4 h and for 16 h was carried out. This third com-
parison provided validation of the data from the other two
comparisons. Dye swaps were included for each experimental
comparison. Macrophages were infected with purified concen-
trated stocks of Malawi LIL20/1 virus, and infection rates of at
least 70%, were obtained. We pooled the RNA from two sets
of experimental infections and carried out experiments using
four separate pools of RNA (i.e., from eight separate animals).
Temporally regulated genes. Approximately 140 of the tar-
gets were eliminated from the analysis because of poor quality.
By using one-way analysis of variance analysis in the Gene-
spring software package, 125 targets were identified as con-
taining differentially regulated genes. Thus, 2,615 targets did
not change in expression level. Differentially regulated genes
were broken down into eight clusters by the K-Mean algo-
rithm. Due to the lack of independent experimental condi-
tions, this clustering is mainly for the purpose of data visual-
ization and presentation. The eight clusters were then
manually separated into three groups (I, II, and III) exhibiting
different temporally regulated expression patterns (Table 1).
Group I contains 87 targets which have increased expression
levels at 4 h postinfection compared to mock-infected cells but
show decreased expression levels at 16 h postinfection com-
pared to levels at 4 h postinfection. Since some of these targets
contained cDNAs encoding the same genes, a total of 77 dif-
ferent differentially expressed genes were identified in this
group, including 62 of known function and 15 of unknown
function.
Group II contains 34 targets which increased in expression
level at 16 h postinfection compared to levels at 4 h postinfec-
tion. Each of these encoded unique genes, including 20 of
known function and 14 of unknown function.
The third group of genes, group III, contains four genes.
Their expression levels were increased at both 4 and 16 h
postinfection compared to levels in mock-infected cells. Three
of these genes were ASFV genes included in the array as an
infection control.
Functional classification of differentially regulated genes.
Within gene group I (increased levels at 4 h postinfection),
several functionally related classes of genes were identified.
One of these classes encoded cytokines and chemokines. These
include the CC chemokines MIP-1, MIP-1, MIP-2, IP-
2, and RANTES and the CXC chemokine AMCF1. Of these,
MIP-1 and MIP-1 consistently showed the highest increase
(n-fold) in expression at 4 h compared to levels in mock-
infected cells, and this varied between three- and fivefold when
we compared different cDNA array spots encoding the same
genes. The only cytokines that showed increased expression
levels in infected cells were those encoding the proinflamma-
tory cytokines IL-1, TNF-, and IFN-. These showed com-
paratively small increases in expression levels which varied
from 1.5- to 2.4-fold compared to those in mock-infected cells
at 4 h postinfection.
A second functional class of genes within group I are those
encoding other cell surface-expressed or -secreted proteins.
Genes which showed a 4-fold increase in transcript levels at
4 h postinfection compared to levels in mock-infected cells
included syndecan 2 (heparan sulfate proteoglycan), galectin 3,
and the mannose receptor. The other cell surface proteins in
group I included CD87 urokinase plasminogen activator re-
ceptor (uPAR); IEX1, a type II membrane protein induced by
radiation treatment, stress, and phorbol esters (28, 31, 43); a
lectin-like, oxidized, low-density lipoprotein receptor (LOX-
1); and annexin 1. An additional gene encoding a secreted
protein in group I was the TNF-stimulated gene 6 product
(TSG-6).
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TABLE 1. Changes (n-fold) in expression levels of genes differentially regulated following ASFV infection
Group and accession no.
for gene on each spot Description
Fold change at:
4 h/mock
infection
16 h/mock
infection 16 h/4 h
Group I (87 targets, 15 unknown)
AJ747345 CCL4/MIP-1, small inducible cytokine A4 4.5 1.1 0.3
AJ747413 No hit 4.3 1.3 0.3
AJ746841 CCL4/MIP-1, small inducible cytokine A4 3.6 1.1 0.4
AJ747490 No hit 3.1 1.0 0.5
AJ746828 CCL4/MIP-1, small inducible cytokine A4 3.3 1.0 0.5
AJ746638 No hit 4.8 1.3 0.3
AJ746803 CCL3/MIP-1, small inducible cytokine A3 3.5 1.2 0.4
AJ747430 No hit 3.7 1.0 0.4
BC028674 EF-1-alpha-1, elongation factor 1-alpha 1 4.5 1.1 0.3
X62001 CATS, cathepsin S 5.0 1.2 0.3
AY368183 MMR, macrophage mannose receptor 3.9 1.3 0.4
BC034992 SNXA, sorting nexin 10 4.1 1.1 0.4
AJ747009 LGALS3, galectin 3 4.1 1.2 0.3
AJ747450 No hit 2.7 0.9 0.3
J04621 SDC2, syndecan-2 precursor (fibroglycan) 4.5 1.3 0.3
AJ747122 CCL3/MIP-1, small inducible cytokine A3 5.0 1.3 0.3
AJ747350 CCL3/MIP-1, small inducible cytokine A3 4.6 1.4 0.3
BC009334 CTC6, protein C20 ORF126 6.4 1.1 0.2
AB006011 JAK2, Janus kinase 2 2.8 0.7 0.3
AJ279008 CATL, cathepsin L precursor 1.6 0.8 0.5
AJ747364 CXCL2 chemokine 1.5 1.0 0.5
AJ746916 ESTD, esterase D 1.6 0.9 0.5
AJ747481 No hit 1.6 0.8 0.5
AM260755 No hit 1.6 0.9 0.6
BE233980 Prostaglandin G/H synthase 2 1.8 1.1 0.6
BE232835 IL-1 1.8 1.0 0.6
AJ747240 ANX1, annexin 1 1.5 1.0 0.6
BE031195 MT1A, metallothionein 1.7 1.0 0.7
BD132522 OBRG, leptin receptor gene-related product 1.8 1.0 0.7
AJ747349 CXCL2 chemokine 1.6 1.2 0.6
AJ747344 CXCL3 chemokine 1.7 1.0 0.6
AJ747109 OCTM4, tetraspan membrane protein 2.1 1.1 0.6
AJ747692 PAI-2, urokinase inhibitor 2.1 0.9 0.5
AJ747354 GDF8, Sus scrofa myostatin gene 2.3 1.1 0.6
AJ746636 NP, purine nucleoside phosphorylase 1.7 0.9 0.6
AJ746832 ARGI, arginase 1 1.5 0.8 0.5
BF442132 UPAR 1.7 0.9 0.6
AJ747334 Similar to RIKEN cDNA 2010003F10 gene 2.1 1.1 0.6
X74568 IL-1 2.4 0.9 0.5
AJ747452 No hit 2.0 0.9 0.5
BF078747 IEX1, radiation-inducible immediate early gene 2.1 0.8 0.5
X57321 TNF- 2.3 1.0 0.7
U95009 CREB, cyclin-AMP-responsive element binding protein 3.0 1.0 0.6
AJ747487 KIAA0266 gene 2.6 1.2 0.5
AJ279057 POL, endogenous retroviral POL polyprotein 1.3 1.0 0.9
AJ746673 UPAR 1.3 1.0 0.8
AJ747410 No hit 1.4 1.0 0.8
AJ747911 DJC7, DnaJ homolog subfamily C member 7 1.4 1.0 0.8
M29079 TNF- 1.5 1.1 0.9
BC030634 Mortalin-2, 70-kDa shock protein 9B 1.4 1.1 0.8
AJ747102 Similar to B-cell phosphoinositide 3-kinase adaptor 1.3 1.1 0.8
AJ746786 CCL5/RANTES, small inducible cytokine A5 1.4 1.1 0.8
AJ746859 CXCL5/AMCF1, chemokine 1.5 1.2 0.8
AJ747474 APOB, apolipoprotein B 1.3 1.0 0.8
AJ747126 CIS1 1.3 1.0 0.8
AJ746642 MIP-1, partial 1.4 1.0 0.8
AM260756 No hit 1.5 1.0 0.8
AJ747469 ERF1, eukaryotic peptide chain release factor 1.5 1.0 0.8
AJ747417 C122, putative alpha-mannosidase C1 ORF22 1.4 1.0 0.9
AJ747862 OXA1, mitochondrial inner membrane protein 1.4 1.0 0.9
Z21968 IB-, NF-B inhibitor alpha 1.2 1.0 0.9
M86762 IFN- 1.3 1.0 0.9
AJ747720 ASFV gene 1.6 1.4 1.0
BI347029 NF-B1, NF-B p50 precursor 1.4 1.0 0.7
AJ746951 PNPH, purine nucleoside phosphorylase 1.5 0.9 0.7
AW316433 STAT2, signal transducer and activator of transcription 2 1.7 1.1 0.8
AJ747878 S3B2, splicing factor 3b subunit 2 1.5 1.0 0.7
AJ747477 No hit 1.4 1.2 0.7
BI342110 TSG-6 1.6 1.1 0.7
BF080110 No hit 1.6 1.0 0.7
BG384374 SFRS3, splicing factor arginine/serine-rich 3 1.2 0.8 0.7
L43124 VCAM1, vascular cell adhesion molecule 1 1.3 0.9 0.8
BI345703 ND2, NADH dehydrogenase subunit 2 1.1 0.9 0.6
AM260754 PPG, platelet proteoglycan core protein, partial 0.9 0.6 0.6
BI342952 DDX5, DEAD box protein p68 1.3 0.8 0.7
BF198233 No hit 1.2 0.8 0.7
Continued on facing page
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A third class of genes in group I encodes components of
intracellular signaling pathways. These include the cyclic-
AMP-responsive transcription factor CREB (delta isoform);
the tyrosine kinase JAK2 and transcription factor STAT 2,
which are involved in IFN-activated signaling pathways; the
NF-B p50 subunit precursor; the IB- inhibitor of NF-B;
and cryopirin (cold-induced autoinflammatory syndrome 1
[CIAS1] protein) (14, 40, 49).
A fourth class of genes in group I is involved in protein
trafficking pathways. These include genes encoding sorting
nexin (SNX) 10 and a leptin receptor gene-related product.
The leptin receptor gene includes the first two untranslated
exons of the leptin receptor gene but expresses a different
protein. This protein contains a Vps55 (PF04133) domain and
is involved in trafficking from late endosomes to vacuoles (4).
A fifth class of genes in group I encode proteins activated by
stress. Of these, open reading frame 126, found on chromo-
some 20, is up-regulated by greater than sixfold, whereas heat
shock protein HSP70 and mortalin-2 shock protein 9B show
relatively small increases in expression level.
A sixth gene class in group I encodes the endosomal/lysoso-
mal cysteine proteases cathepsin S and L. Cathepsin S is up-
regulated almost 5-fold, whereas cathepsin L is up-regulated
1.5- to 2-fold.
TABLE 1—Continued
Group and accession no.
for gene on each spot Description
Fold change at:
4 h/mock
infection
16 h/mock
infection 16 h/4 h
BG834863 RNA-binding protein FUS 1.3 1.0 0.7
BF189184 No hit 1.2 0.9 0.8
BI338506 GLUL, glutamate-ammonia ligase 1.2 0.7 0.7
BI338939 NF-B1, NF-B p100/p49 subunits 1.3 0.9 0.8
AJ746964 HSPA8, 70-kDa heat shock protein 8 1.1 0.9 0.8
AW425011 Heterogeneous nuclear D-like ribonucleoprotein 1.1 1.0 0.8
BE236016 No hit 1.4 0.9 0.7
BC000178 KCMF1, potassium channel modulatory factor 1.3 0.9 0.7
Z21968 IB- 1.4 0.8 0.7
BI341366 Glrx1, glutaredoxin 1.3 1.0 0.7
BG383949 LOX1, lectin-like oxidized low-density lipoprotein receptor 1 1.4 0.8 0.6
Group II (34 targets, 14 unknown)
BG384562 No hit 0.7 0.8 1.1
BG384417 NAGK, N-acetylglucosamine kinase 0.7 0.9 1.1
AM260789 S100a6, S100 calcium-binding protein A6 (calcyclin) 0.7 0.9 1.2
AJ747011 No hit 0.5 0.8 1.1
AW479942 TKT, transketolase 0.7 0.9 1.0
AJ747897 No hit 0.7 0.9 1.3
AJ747223 Progesterone membrane-binding protein 0.7 0.9 1.3
BG383269 PGR, 15 oxoprostaglandin 13-reductase 0.5 0.8 1.3
BG609005 No hit 0.6 0.8 1.3
BG834532 Hypothetical protein CGI-128 0.9 1.1 1.3
AJ746996 GNS, N-acetylglucosamine 6 sulfatase 0.8 1.0 1.2
BI338320 RPS18, 40S ribosomal protein S18 0.8 1.0 1.3
AW436618 No hit 0.8 1.1 1.3
BI467643 CARD6, caspase recruitment domain protein 1.0 1.1 1.3
BF444373 No hit 0.9 1.1 1.3
BE013887 No hit 0.8 1.1 1.3
BF190002 RPP2D, acidic ribosomal protein P2 0.8 1.1 1.3
BI346405 PRST, prostein protein 0.8 1.0 1.2
BF192896 Pparg, peroxisome proliferator-activated receptor 0.7 1.0 1.2
BF442098 No hit 0.9 1.0 1.2
BG732923 No hit 0.8 1.0 1.2
BG382031 P26452, 40S ribosomal protein P40 0.9 1.1 1.2
AW435754 CSAD, cysteine sulfinic acid decarboxylase 0.9 1.0 1.2
AW308265 PLAU, urokinase-type plasminogen activator 0.9 1.1 1.2
BE013644 Ptgis, prostaglandin I2 (prostacyclin) synthase 0.9 1.0 1.2
BI340632 No hit 1.0 1.1 1.4
BE014284 No hit 0.9 1.1 1.4
BF198933 CISY, citrate synthase, mitochondrial precursor 0.8 1.2 1.3
BI341443 No hit 1.1 1.4 1.6
BI360720 No hit 1.0 1.7 2.0
BG384920 RAD51L3, TRAD, DNA repair protein 1.3 2.6 3.0
AJ747845 No hit 1.3 2.7 2.5
AJ747820 MHC1 SLA gene 1.1 1.5 1.7
AJ747815 Lysosomal glucocerebrosidase precursor 1.1 1.9 1.8
Group III (4 targets, 1 unknown)
AJ747727 ASFV O174L 11.9 15.2 1.4
AJ747714 No hit 4.2 3.4 1.3
AJ747717 ASFV V118 13.2 13.3 0.8
AJ747734 ASFV J319L ORF15L 8.0 10.5 1.1
RNA extracted from ASFV Malawi LIL20/1 isolate-infected or mock-infected porcine macrophages was labeled with Cy5 or Cy3 dye and hybridized to porcine cDNA
microarrays. Data were extracted and analyzed as described in Materials and Methods. “No hit” indicates that no matches with known genes were identified. Shown
are the changes (n-fold) in expression level for the three comparisons: infected macrophages at 4 h versus mock-infected macrophages (4 h/mock infection), infected
macrophages at 16 h versus mock-infected macrophages (16 h/mock infection), and infected macrophages at 16 h versus infected macrophages at 4 h (16 h/4 h). Values
were calculated as described in Materials and Methods.
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Additional functional classes in group I encode translation
factors and nucleotide binding and metabolism factors, such as
translation elongation factor 1, termination factor ETF1
(eRF1), splicing factors 3b subunit 2, and arginine/serine-rich
factor 3.
Other group I genes encode proteins which may alter the
function of macrophages. One of these, arginase 1, is involved
in the degradation of arginine to provide polyamine biosynthe-
sis precursors. Arginine is also used as a precursor for NO
synthesis, and arginase activation can negatively influence NO
production. The activation of arginase is an indicator of the
alternative activation pathway of macrophages induced by type
II rather than type I cytokines (7, 8). A cDNA encoding pros-
taglandin G/H synthase 2 was also in group I (27, 48, 54).
Temporally regulated group II contained 34 genes whose
expression levels were either slightly down-regulated or slightly
up-regulated at 4 h postinfection compared to levels in mock-
infected controls but increased during the infection period. For
example, the transcriptional levels of DNA repair protein
RAD51 homolog 4, cytochrome P450, and major histocompat-
ibility complex class I swine leucocyte antigen in cluster 7
showed just a small increase at 4 h, and by 16 h, their expres-
sion levels had increased two- to threefold compared to levels
in mock-infected cells.
The one host gene included in group III is of unknown
function.
Real-time PCR analysis of differentially expressed genes.
Transcript levels of 12 genes were measured by real-time PCR
using -actin as the internal control. The comparisons carried
out were the same as in the microarray experiments. For most
genes, the relative expression levels obtained by real-time PCR
were consistent with those obtained in the microarray experi-
ments (Table 2). In the comparison between RNAs from mac-
rophages infected for 16 h and 4 h, the two techniques gave
very similar expression levels for all 12 genes. There were some
discrepancies in the other two comparisons. For example, real-
time PCR results showed much higher increases (n-fold) than
the results of the microarray analysis for TNF- in the com-
parisons of cells infected at both 4 and 16 h with mock-infected
cells. In addition, the expression levels for IB- and HSP70
were slightly up-regulated at 4 h and almost the same as in
mock-infected cells at 16 h postinfection according to the mi-
croarray data but about two- to threefold down-regulated com-
pared to levels in mock-infected cells according to the real-
time PCR data. These inconsistencies were probably due to the
intrinsic difference between these two techniques, notably, in
the normalization methods. For microarray experiments, the
normalization was based on a large number of genes, whereas
in real-time PCR experiments, a single housekeeping gene was
used as an internal control against which results were normal-
ized.
Accumulation and secretion of IL-1 and TNF- during
ASFV infection. To investigate changes at the protein levels of
two of the differentially regulated genes, we measured the
expression and secretion levels of two proinflammatory cyto-
kines, IL-1 and TNF-. Macrophages were mock treated,
continually stimulated with 1 g/ml LPS, or infected with the
virulent ASFV Malawi LIL20/1 or nonpathogenic OUR T88/3
isolate. As shown in Fig. 1A, only the 31-kDa precursor of
IL-1 was detected in the cell lysates by Western blotting. At
early time points, 2 and 4 h posttreatment, both LPS treatment
and ASFV infection induced a greater accumulation of pro-
IL-1 synthesis than mock treatment in macrophages. This
correlates with the microarray result that macrophages in-
fected with the ASFV Malawi LIL20/1 isolate showed higher
transcription levels of IL-1 than uninfected cells at 4 h postin-
fection. By 6 h posttreatment, similar intracellular pools of
pro-IL-1 were present in all four groups of cells, and these
were maintained until the end of the time course, at 24 h
posttreatment.
The amounts of IL-1 estimated by ELISA that were se-
creted from macrophages infected with the Malawi LIL20/1
isolate were about sixfold greater by 23 h postinfection than
with mock treatment, LPS stimulation, or OUR T88/3 infec-
tion (Fig. 1B). As shown above, a large pool of pro-IL-1 is
present in both uninfected and infected cells. Although intra-
cellular levels increased slightly during ASFV infection, the
major mechanism regulating the differential release of IL-1
into the medium must involve the control of processing and
secretion pathways.
The precursor and mature forms of TNF- were detected by
Western blotting in cell lysates. The amounts of intracellular
TNF- were greatly increased following LPS stimulation (Fig.
1C). Slightly increased levels of intracellular TNF- were de-
tected in cells infected with both viruses compared to levels in
mock-infected cells at 4 h postinfection. By 22 h postinfection,
levels of intracellular TNF- had declined in cells infected with
the Malawi LIL20/1 isolate and in mock-infected cells but
remained slightly elevated in cells infected with the OUR
T88/3 isolate.
Only the mature form of TNF- was detected in cell super-
natants, as expected. LPS treatment stimulated the greatest
secretion of TNF-, and this was detected from early times
onward. At 22 h postinfection, small amounts of TNF- were
TABLE 2. Comparison of changes (n-fold) determined by
microarray analysis and real-time PCRa
Gene
Change (n-fold)
Microarray Real-time PCR
4 h/mock
infection
16 h/mock
infection 16 h/4 h
4 h/mock
infection
16 h/mock
infection 16 h/4 h
TNF- 1.8 1.1 0.8 9.8 4.1 0.4
MIP-1 3.8 1.0 0.4 6.9 1.9 0.3
IL-1 2.1 0.9 0.6 2.3 1.0 0.4
VCAM 1.3 0.9 0.8 2.0 0.8 0.4
JAK2 2.8 0.7 0.3 1.7 0.8 0.5
ICAM1 1.4 1.1 0.8 3.6 1.8 0.5
AMCF1 1.5 1.2 0.8 2.1 0.9 0.8
PTGS2 1.8 1.1 0.6 2.2 0.9 0.4
CD87 1.7 0.9 0.6 2.3 1.1 0.5
P50 1.4 1.0 0.7 2.6 2.1 0.8
IB- 1.3 0.9 0.8 0.5 0.3 0.7
HSP70 1.1 0.9 0.8 0.6 0.5 1.0
a Quantitative real-time PCR was carried out as described in Materials and
Methods for the selection of the indicated differentially regulated genes. Shown
are changes (n-fold) between infected cells at 4 h and mock-infected cells (4
h/mock infection), infected cells at 16 h and mock-infected cells (16 h/mock
infection), and infected cells at 16 h and infected cells at 4 h (16 h/4 h). The
values from the microarray analysis are geometric means based upon replicates
with each gene.
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detected in supernatants from cells infected with each virus as
well as from mock-infected cells. Some variation was observed
between macrophage cultures from different pigs in the levels
of TNF- and IL-1 present in cell lysates and secreted from
cells. In particular, variation was observed in the background
levels observed in mock-infected macrophages probably due to
differences in the activation state induced by culture condi-
tions. However, in experiments that we carried out using mac-
rophages from six different pigs, we always observed an in-
creased expression level at early times postinfection compared
to the level in mock-infected cells.
DISCUSSION
The data presented are the first analysis of changes in por-
cine macrophage gene transcription that occur following in
vitro infection with a highly virulent ASFV isolate. This anal-
ysis had the advantage of studying the effects of virus replica-
tion using the target species and main target cells for the virus.
This showed that the majority of the genes analyzed (2,615
from 2,740) did not alter in transcription level during infection
compared to levels in mock-infected cells. Thus, there is no
general “switch-off” of host transcription during virus infec-
tion. This agrees with previous results which showed, by re-
verse transcription-PCR, that transcript levels of some consti-
tutively expressed genes do not change during ASFV infection
(19, 20, 44).
The majority of the differentially regulated genes showed a
pattern of temporal expression characterized by increased ex-
pression levels at 4 h postinfection compared to levels in mock-
infected cells, with a return in expression level at 16 h postin-
fection to levels equivalent to those in mock-infected cells.
Genes in this group fell into several functional classes and
included a number of genes whose transcription is predicted to
be activated as part of the host response to clear virus infec-
tion. For example, we observed an early transcriptional activa-
tion of proinflammatory cytokine genes encoding IL-6, TNF-,
IFN-, and chemokines of the CC and CXC groups. Increased
expression of these cytokines and chemokines resulting in re-
cruitment and activation of inflammatory cells might also favor
virus replication by providing an additional pool of macro-
phages that are susceptible to infection. Transcript levels of
several genes involved in intracellular signaling pathways acti-
vated by proinflammatory cytokines were also increased at
early times. These included Jak 2, STAT 1, CREB, and a
phosphoinositide 3-kinase adaptor.
We also observed increased transcript levels at early times
for several genes which can have an anti-inflammatory role.
These included the gene encoding cryopyrin/CIAS1. Cryopyrin
is an inflammation mediator that can act upstream of IB to
FIG. 1. Intracellular accumulation and secretion of IL-1 and TNF-. Western blotting and ELISA assays were employed to investigate the
intracellular accumulation and secretion of IL-1 and TNF- as described in Materials and Methods. Alveolar macrophages were prepared from
piglets and cultured in six-well plates. They were mock treated, continually stimulated with 1 g/ml of LPS, or infected with the ASFV Malawi
LIL20/1 or OUR T88/3 isolate. Cell lysates were prepared at 2, 4, 6, 8, 10, and 24 h posttreatment. Cell culture supernatants were also collected
at 3, 5, 7, 9, and 23 h posttreatment to measure the secreted proteins. Western blotting was used to detect intracellular IL-1 (A). The positions
of the 31-kDa pro-IL-1 and of beta-actin (44 kDa) are indicated. Quantitative ELISA were used to measure secreted IL-1 (B). ELISA results
were expressed as geometric means 	 standard deviations of three measurements. TNF- was detected by Western blotting in extracts from cell
lysates and in medium from infected or mock-infected macrophages. The positions of pro-TNF- and mature TNF- are marked (C).
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inhibit activation of NF-B (40). The TNF-stimulated gene 6
protein, TSG-6, is a secreted protein with an anti-inflammatory
role (3, 12, 34, 36). Increased transcription of these anti-in-
flammatory genes may play a role in suppressing the proin-
flammatory response.
Genes encoding several other cell surface or secreted pro-
teins were up-regulated at early times postinfection. One of
these encodes syndecan 2 (heparan sulfate proteoglycan),
which has been shown to bind to IL-8 and, by binding to
collagen, to reduce cell invasiveness (11, 25, 30, 32, 51). A
second gene encodes galectin 3, a member of a family of
galactose binding lectins with important roles in regulating
homeostasis within the immune system. Galectin 3 can be
expressed on the cell surface, nucleus, and cytoplasm or be
secreted from cells. In the cytoplasm, galectin 3 binds to bcl-2
and can protect cells from apoptosis, and in the nucleus, it has
growth-promoting activities. However, when present on the
cell surface or secreted from cells, galectin 3 can induce apop-
tosis in bystander cells (18, 45, 46). If changes in the amount of
active galectin 3 protein also occurs, this may provide an ad-
ditional mechanism by which infected cells are protected from
apoptosis until after virus replication. Conversely, galectin 3
expressed on the surfaces of or secreted from infected cells
may play a role in the induction of apoptosis in bystander
lymphocytes (29, 35, 45, 55).
Increased transcript levels of several genes encoding pro-
teins which are involved in the presentation of peptides in
conjunction with major histocompatibility complex class II
were observed early postinfection. These genes included those
encoding the mannose receptor and the proteases cathepsin S
and L, the latter of which is involved in the processing of
exogenous peptides. Cathepsin L is also known to cleave the
precursor of IL-8.
The uPAR gene (CD87) was also up-regulated at early
times. uPA and uPAR exert pleiotropic functions over both
physiological and pathological processes involving inflamma-
tion, fibrinolysis, and tissue repair. By anchoring uPA at the
cell surface, uPAR regulates cell migration, adhesion, and pro-
liferation, influencing inflammatory and immune responses
(5, 39).
The return to base-level transcription of genes in group I at
late times postinfection may be due to the actions of virus-
encoded proteins or to other host feedback mechanisms acting
on infected cells. Expression of the A238L protein has already
been shown to cause the down-regulation of transcription from
the TNF- and COX2 promoters (23, 24). Deletion of several
members of multigene families 360 and 530 caused an increase
in transcription of IFN- (2). Although virus genes are ex-
pressed immediately following virus entry, the accumulation of
proteins expressed to sufficient levels to be effective may re-
quire several hours. Hence, if these virus proteins are involved,
the delay in observing an effect on “dampening” host transcrip-
tion profiles is expected. The two other groups of differentially
regulated genes, groups II and III, showed increased transcript
levels at 16 h postinfection compared to levels in mock-in-
fected cells. Possibly, these groups of genes may include some
that encode proteins which are advantageous for virus replica-
tion.
Our results showed that infection of cells with the Malawi
LIL20/1 isolate induced the secretion of much higher levels of
IL-1 than the nonpathogenic OUR T88/3 isolate and that this
increased secretion is likely to be regulated at the level of
processing or release from cells rather than from changes in
the amount of the transcript.
The amount of intracellular pro-TNF- was increased
slightly in cells infected with both the Malawi LIL20/1 and the
OUR T88./3 isolate compared to the amount in mock-infected
cells at 4 h postinfection. At 22 h postinfection, levels of pro-
TNF- remained elevated in lysates from cells infected with
the OUR T88/3 isolate, whereas levels decreased in cells in-
fected with the Malawi LIL20/1 isolate. We observed only
slight differences in TNF- protein levels in infected macro-
phages from those in mock-infected macrophages, whereas
real-time PCR and microarray analysis demonstrated a greater
increase in transcript levels in macrophages infected with the
Malawi LIL20/1 isolate than in mock-infected macrophages.
This suggests that posttranscriptional events such as protein
stability are important in determining the levels of protein
accumulated. One previous study (19) compared the levels of
transcription of cytokines in macrophages infected with low-
and high-virulence ASFV isolates. These results showed sig-
nificantly increased levels of transcripts for TNF-, IL-6, IL-12,
and IL-15 in macrophages infected with a low-virulence iso-
late, NHP68, compared to levels in macrophages infected with
the high-virulence isolate Lis 60. The differential secretion of
proinflammatory cytokines from macrophages infected with
the low- and high-virulence isolates may be of significance in
virus pathology and will be further investigated.
This study is a useful first step in screening a wide range of
host genes for potential virus-induced changes in RNA levels
and provides a preliminary identification of some of the host
genes that may be differentially regulated. Data from the mi-
croarray experiments provide a foundation for further studies,
at the functional level, into the molecular basis of ASFV
pathogenesis and virus mechanisms of immune evasion.
ACKNOWLEDGMENTS
We thank the Biological and Biotechnological Science Research
Council (BBSRC) and the Department of the Environment, Food, and
Rural Affairs (DEFRA) for funding.
We thank Mark Fell for assistance in annotating the array data.
REFERENCES
1. Afonso, C. L., C. Alcaraz, A. Brun, M. D. Sussman, D. V. Onisk, J. M.
Escribano, and D. L. Rock. 1992. Characterization of P-30, a highly antigenic
membrane and secreted protein of African swine fever virus. Virology 189:
368–373.
2. Afonso, C. L., M. E. Piccone, K. M. Zaffuto, J. Neilan, G. F. Kutish, Z. Lu,
C. A. Balinsky, T. R. Gibb, T. J. Bean, L. Zsak, and D. L. Rock. 2004. African
swine fever virus multigene family 360 and 530 genes affect host interferon
response. J. Virol. 78:1858–1864.
3. Bardos, T., R. V. Kamath, K. Mikecz, and T. T. Glant. 2001. Anti-inflam-
matory and chondroprotective effect of TSG-6 (tumor necrosis factor-alpha-
stimulated gene-6) in murine models of experimental arthritis. Am. J. Pathol.
159:1711–1721. (Erratum, 160:1193, 2002.)
4. Belgareh-Touze, N., S. Avaro, Y. Rouille, B. Hoflack, and R. Haguenauer-
Tsapis. 2002. Yeast Vps55p, a functional homolog of human obesity receptor
gene-related protein, is involved in late endosome to vacuole trafficking.
Mol. Biol. Cell 13:1694–1708.
5. Blasi, F., and P. Carmeliet. 2002. uPAR: a versatile signalling orchestrator.
Nat. Rev. Mol. Cell Biol. 3:932–943.
6. Boinas, F. S., G. H. Hutchings, L. K. Dixon, and P. J. Wilkinson. 2004.
Characterization of pathogenic and non-pathogenic African swine fever vi-
rus isolates from Ornithodoros erraticus inhabiting pig premises in Portugal.
J. Gen. Virol. 85:2177–2187.
7. Bronte, V., P. Serafini, C. De Santo, I. Marigo, V. Tosello, A. Mazzoni, D. M.
Segal, C. Staib, M. Lowel, G. Sutter, M. P. Colombo, and P. Zanovello. 2003.
10520 ZHANG ET AL. J. VIROL.
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing
mice. J. Immunol. 170:270–278.
8. Bronte, V., P. Serafini, A. Mazzoni, D. M. Segal, and P. Zanovello. 2003.
L-Arginine metabolism in myeloid cells controls T-lymphocyte functions.
Trends Immunol. 24:302–306.
9. Carrasco, L., F. C. M. deLara, J. M. delasMulas, J. C. GomezVillamandos,
J. Perez, P. J. Wilkinson, and M. A. Sierra. 1996. Apoptosis in lymph nodes
in acute African swine fever. J. Comp. Pathol. 115:415–428.
10. Carrasco, L., A. Fernandez, J. C. G. Villamandos, E. Mozos, A. Mendez, and
A. Jover. 1992. Kupffer cells and PIMs in acute experimental African swine
fever. Histol. Histopathol. 7:421–425.
11. Chen, L. G., C. Klass, and A. Woods. 2004. Syndecan-2 regulates transform-
ing growth factor-beta signaling. J. Biol. Chem. 279:15715–15718.
12. Day, A. J., and G. D. Prestwich. 2002. Hyaluronan-binding proteins: tying up
the giant. J. Biol. Chem. 277:4585–4588.
13. Dixon, L. K., J. M. Escribano, C. Martins, D. L. Rock, M. L. Salas, and P. J.
Wilkinson. 2005. Asfarviridae, p. 135–143. In C. M. Fauquet, M. A. Mayo, J.
Maniloff, U. Desselberger, and L. A. Ball (ed.), Virus taxonomy: classifica-
tion and nomenclature of viruses. Seventh report of the International Com-
mittee on Taxonomy of Viruses. Elsevier/Academic Press, London, United
Kingdom.
14. Dowds, T. A., J. Masumoto, F. F. Chen, Y. Ogura, N. Inohara, and G. Nunez.
2003. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Medi-
terranean fever gene product. Biochem. Biophys. Res. Commun. 302:575–
580.
15. Fernandez, A., J. Perez, L. Carrasco, M. J. Bautista, J. M. Sanchezvizcaino,
and M. A. Sierra. 1992. Distribution of ASFV antigens in pig tissues exper-
imentally infected with 2 different Spanish virus isolates. Zentbl. Vetmed.
Reihe B 39:393–402.
16. Fernandez, A., J. Perez, L. Carrasco, M. A. Sierra, M. Sanchezvizcaino, and
A. Jover. 1992. Detection of African swine fever viral antigens in paraffin-
embedded tissues by use of immunohistologic methods and polyclonal anti-
bodies. Am. J. Vet. Res. 53:1462–1467.
17. Fernandez, A., J. Perez, J. M. Delasmulas, L. Carrasco, J. Dominguez, and
M. A. Sierra. 1992. Localization of African swine fever viral antigen, swine
Igm, Igg and C1q in lung and liver tissues of experimentally infected pigs.
J. Comp. Pathol. 107:81–90.
18. Fukumori, T., Y. Takenaka, T. Yoshii, H. R. C. Kim, V. Hogan, H. Inohara,
S. Kagawa, and A. Raz. 2003. CD29 and CD7 mediate galectin-3-induced
type II T-cell apoptosis. Cancer Res. 63:8302–8311.
19. Gil, S., M. Spagnuolo-Weaver, A. Canals, N. Sepulveda, J. Oliveira, A.
Aleixo, G. Allan, A. Leitao, and C. L. V. Martins. 2003. Expression at mRNA
level of cytokines and A238L gene in porcine blood-derived macrophages
infected in vitro with African swine fever virus (ASFV) isolates of different
virulence. Arch.Virol. 148:2077–2097.
20. Gomez del Moral, M., E. Ortuno, P. Fernandez-Zapatero, F. Alonso, C.
Alonso, A. Ezquerra, and J. Dominguez. 1999. African swine fever virus
infection induces tumor necrosis factor alpha production: implications in
pathogenesis. J. Virol. 73:2173–2180.
21. Gomez-Villamandos, J. C., J. Hervas, A. Mendez, L. Carrasco, J. Martin de
las Mulas, C. J. Villeda, P. J. Wilkinson, and M. A. Sierra. 1995. Experi-
mental African swine fever: apoptosis of lymphocytes and virus replication in
other cells. J. Gen. Virol. 76:2399–2405.
22. Gomez-Villamandos, J. C., J. Hervas, A. Mendez, L. Carrasco, C. J. Villeda,
P. J. Wilkinson, and M. A. Sierra. 1995. A pathological study of the perisi-
nusoidal unit of the liver in acute African swine fever. Res. Vet. Sci. 59:146–
151.
23. Granja, A. G., M. L. Nogal, C. Hurtado, C. del Aguila, A. L. Carrascosa,
M. L. Salas, M. Fresno, and Y. Revilla. 2006. The viral protein A238L
inhibits TNF-alpha expression through a CBP/p300 transcriptional coactiva-
tor pathway. J. Immunol. 176:451–462.
24. Granja, A. G., M. L. Nogal, C. Hurtado, V. Vila, A. L. Carrascosa, M. L.
Salas, M. Fresno, and Y. Revilla. 2004. The viral protein A238L inhibits
cyclooxygenase-2 expression through a nuclear factor of activated T cell-
dependent transactivation pathway. J. Biol. Chem. 279:53736–53746.
25. Halden, Y., A. Rek, W. Atzenhofer, L. Szilak, A. Wabnig, and A. J. Kungl.
2004. Interleukin-8 binds to syndecan-2 on human endothelial cells. Bio-
chem. J. 377:533–538.
26. Haresnape, J. M., and P. J. Wilkinson. 1989. A study of African swine fever
virus-infected ticks (Ornithodoros-Moubata) collected from 3 villages in the
Asf enzootic area of Malawi following an outbreak of the disease in domestic
pigs. Epidemiol. Infect. 102:507–522.
27. Herschman, H. R., W. L. Xie, and S. Reddy. 1999. Function and regulation
of prostaglandin synthase 2. Adv. Exp. Med. Biol. 469:3–8.
28. Hofmann, W. K., S. de Vos, M. Komor, D. Hoelzer, W. Wachsman, and H. P.
Koeffler. 2002. Characterization of gene expression of CD34() cells from
normal and myelodysplastic bone marrow. Blood 100:3553–3560.
29. Hsu, D. K., and F. T. Liu. 2002. Regulation of cellular homeostasis by
galectins. Glycoconj. J. 19:507–515.
30. Klass, C. M., J. R. Couchman, and A. Woods. 2000. Control of extracellular
matrix assembly by syndecan-2 proteoglycan. J. Cell Sci. 113:493–506.
31. Kondratyev, A. D., K. N. Chung, and M. O. Jung. 1996. Identification and
characterization of a radiation-inducible glycosylated human early-response
gene. Cancer Res. 56:1498–1502.
32. Kusano, Y., Y. Yoshitomi, S. Munesue, M. Okayama, and K. Oguri. 2004.
Cooperation of syndecan-2 and syndecan-4 among cell surface heparan sul-
fate proteoglycans in the actin cytoskeletal organization of Lewis lung car-
cinoma cells. J. Biochem. 135:129–137.
33. Leitao, A., C. Cartaxeiro, R. Coelho, B. Cruz, R. M. E. Parkhouse, F. C.
Portugal, J. D. Vigario, and C. L. V. Martins. 2001. The non-haemadsorbing
African swine fever virus isolate ASFV/NH/P68 provides a model for defin-
ing the protective anti-virus immune response. J. Gen. Virol. 82:513–523.
34. Lesley, J., I. Gal, D. J. Mahoney, M. R. Cordell, M. S. Rugg, R. Hyman, A. J.
Day, and K. Mikecz. 2004. TSG-6 modulates the interaction between hyal-
uronan and cell surface CD44. J. Biol. Chem. 279:25745–25754.
35. Liu, F. T., R. J. Patterson, and J. L. Wang. 2002. Intracellular functions of
galectins. Biochim. Biophys. Acta 1572:263–273.
36. Milner, C. M., and A. J. Day. 2003. TSG-6: a multifunctional protein asso-
ciated with inflammation. J. Cell Sci. 116:1863–1873.
37. Miskin, J. E., C. C. Abrams, and L. K. Dixon. 2000. African swine fever virus
protein A238L interacts with the cellular phosphatase calcineurin via a
binding domain similar to that of NFAT. J. Virol. 74:9412–9420.
38. Miskin, J. E., C. C. Abrams, L. C. Goatley, and L. K. Dixon. 1998. A viral
mechanism for inhibition of the cellular phosphatase calcineurin. Science
281:562–565.
39. Mondino, A., and F. Blasi. 2004. uPA and uPAR in fibrinolysis, immunity
and pathology. Trends Immunol. 25:450–455.
40. O’Connor, W., Jr., J. A. Harton, X. S. Zhu, M. W. Linhoff, and J. P. Y. Ting.
2003. Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1
is an inducible inflammatory mediator with NF-kappa B suppressive prop-
erties. J. Immunol. 171:6329–6333.
41. Oura, C. A. L., P. P. Powell, and R. M. E. Parkhouse. 1998. African swine
fever: a disease characterized by apoptosis. J. Gen. Virol. 79:1427–1438.
42. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in
real-time RT-PCR. Nucleic Acids Res. 29:e45.
43. Pietzsch, A., C. Buchler, C. Aslanidis, and G. Schmitz. 1997. Identification
and characterization of a novel monocyte/macrophage differentiation-de-
pendent gene that is responsive to lipopolysaccharide, ceramide, and lyso-
phosphatidylcholine. Biochem. Biophys. Res. Commun. 235:4–9.
44. Powell, P. P., L. K. Dixon, and R. M. E. Parkhouse. 1996. An IB homolog
encoded by African swine fever virus provides a novel mechanism for down-
regulation of proinflammatory cytokine responses in host macrophages.
J. Virol. 70:8527–8533.
45. Rabinovich, G. A., L. G. Baum, N. Tinari, R. Paganelli, C. Natoli, F. T. Liu,
and S. Iacobelli. 2002. Galectins and their ligands: amplifiers, silencers or
tuners of the inflammatory response? Trends Immunol. 23:313–320.
46. Rabinovich, G. A., N. Rubinstein, and L. Fainboim. 2002. Unlocking the
secrets of galectins: a challenge at the frontier of glyco-immunology. J. Leu-
kocyte Biol. 71:741–752.
47. Revilla, Y., M. Callejo, J. M. Rodriguez, E. Culebras, M. L. Nogal, M. L.
Salas, E. Vinuela, and M. Fresno. 1998. Inhibition of nuclear factor kappa B
activation by a virus-encoded I kappa B-like protein. J. Biol. Chem. 273:
5405–5411.
48. Robida, A. M., K. M. Xu, M. L. Ellington, and T. J. Murphy. 2000. Cyclo-
sporin A selectively inhibits mitogen-induced cyclooxygenase-2 gene tran-
scription in vascular smooth muscle cells. Mol. Pharmacol. 58:701–708.
49. Rosengren, S., H. M. Hoffman, G. S. Firestein, and D. L. Boyle. 2003.
Expression of cryopyrin and ASC in rheumatoid arthritis (RA) synovium and
fibroblast-like synoviocytes. Arthritis Rheum. 48:1406.
50. Villeda, C. J., S. M. Williams, P. J. Wilkinson, and E. Vinuela. 1993. Hae-
mostatic abnormalities in African swine fever: a comparison of two virus
strains of different virulence (Dominican Republic 
78 and Malta 
78). Arch.
Virol. 130:71–83.
51. Villena, J., C. Berndt, F. Granes, M. Reina, and S. Vilaro. 2003. Syndecan-2
expression enhances adhesion and proliferation of stably transfected Swiss
3T3 cells. Cell Biol. Int. 27:1005–1010.
52. Wilkinson, P. J. 1984. The persistence of African swine fever in Africa and
the Mediterranean. Prev. Vet. Med. 2:71–82.
53. Wilkinson, P. J., R. C. Wardley, and S. M. Williams. 1981. African swine
fever virus (Malta-78) in pigs. J. Comp. Pathol. 91:277–284.
54. Xie, W. L., and H. R. Herschman. 1996. Transcriptional regulation of pros-
taglandin synthase 2 gene expression by platelet-derived growth factor and
serum. J. Biol. Chem. 271:31742–31748.
55. Yu, F., R. L. Finley, A. Raz, and H. R. C. Kim. 2002. Galectin-3 translocates
to the perinuclear membranes and inhibits cytochrome c release from the
mitochondria—a role for synexin in galectin-3 translocation. J. Biol. Chem.
277:15819–15827.
VOL. 80, 2006 MACROPHAGE TRANSCRIPTIONAL RESPONSES TO ASFV INFECTION 10521
